Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN vs BELIMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN vs BELIMUMAB: Safety Overview

Metric BELANTAMAB MAFODOTIN BELIMUMAB
Total FAERS Reports 2,293 26,773
Deaths Reported 843 788
Death Rate 36.8% 2.9%
Hospitalizations 599 3,771
Average Patient Age 67.3 yrs 47.2 yrs
% Female Patients 39.2% 93.3%
Manufacturer GlaxoSmithKline LLC GlaxoSmithKline LLC
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status N/A Prescription